Home
Olav Dahl's picture
  • E-mailolav.dahl@uib.no
  • Visitor Address
    Haukeland universitetssykehus, Laboratoriebygget
    5009 Bergen
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • Show author(s) (2018). Rare genetic variation in mitochondrial pathways influences the risk for parkinson's disease. Movement Disorders. 1591-1600.
  • Show author(s) (2017). Risk of carotid blowout after reirradiation with particle therapy. Advances in Radiation Oncology. 465-474.
  • Show author(s) (2017). Linear energy transfer distributions in the brainstem depending on tumour location in intensity-modulated proton therapy of paediatric cancer. Acta Oncologica. 763-768.
  • Show author(s) (2017). Identification of a sixteen-microRNA signature as prognostic biomarker for stage II and III colon cancer. OncoTarget. 87837-87847.
  • Show author(s) (2016). Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: A report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA). Annals of Oncology. 1299-1304.
  • Show author(s) (2016). Serum BAFF and APRIL levels, T-lymphocyte subsets, and immunoglobulins after B-cell depletion using the monoclonal anti-CD20 antibody rituximab in myalgic encephalopathy/chronic fatigue syndrome. PLOS ONE.
  • Show author(s) (2016). Prognostic significance of S100A4 expression in stage II and III colorectal cancer: results from a population-based series and a randomized phase III study on adjuvant chemotherapy. Cancer Medicine. 1840-1849.
  • Show author(s) (2016). Multimodal therapy is feasible in elderly anal cancer patients. Acta Oncologica. 81-87.
  • Show author(s) (2016). Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome. JCI Insight.
  • Show author(s) (2016). LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer. Acta Oncologica. 1425-1433.
  • Show author(s) (2016). Aspects of posttraumatic stress disorder in long-term testicular cancer survivors: cross-sectional and longitudinal findings. Journal of cancer survivorship. 842-849.
  • Show author(s) (2015). Validity of Norwegian Rectal Cancer Registry data at a major university hospital 1997-2005. Acta Oncologica. 1723-1728.
  • Show author(s) (2015). Nuclear maspin expression as a predictive marker for fluorouracil treatment response in colon cancer. Acta Oncologica. 470-479.
  • Show author(s) (2015). Nationwide improvement of rectal cancer treatment outcomes in Norway, 1993-2010. Acta Oncologica. 1714-1722.
  • Show author(s) (2015). CXCR4, CXCL12 and the relative CXCL12-CXCR4 expression as prognostic factors in colon cancer. Tumour Biology. 1-12.
  • Show author(s) (2015). Bilateral testicular germ cell tumors in patients treated for clinical stage I non-seminoma within two risk-adapted SWENOTECA protocols. Acta Oncologica. 493-499.
  • Show author(s) (2015). B-lymphocyte depletion in myalgic encephalopathy/chronic fatigue syndrome. An open-label phase II study with rituximab maintenance treatment. PLOS ONE.
  • Show author(s) (2014). One course of adjuvant BEP in clinical stage I nonseminoma mature and expanded results from the SWENOTECA group. Annals of Oncology. 2167-2172.
  • Show author(s) (2014). Anal carcinoma - Survival and recurrence in a large cohort of patients treated according to Nordic guidelines. Radiotherapy and Oncology. 352-358.
  • Show author(s) (2013). Investigation of six testicular germ cell tumor susceptibility genes suggests a parent-of-origin effect in SPRY4. Human Molecular Genetics. 3373-3380.
  • Show author(s) (2013). Impaired health-related quality of life after chemoradiotherapy for anal cancer: Late effects in a national cohort of 128 survivors. Acta Oncologica. 736-744.
  • Show author(s) (2013). Genetic variation in AKT1, PTEN and the 8q24 locus, and the risk of testicular germ cell tumor. Human Reproduction. 1995-2002.
  • Show author(s) (2013). Faecal incontinence after chemoradiotherapy in anal cancer survivors: Long-term results of a national cohort. Radiotherapy and Oncology. 55-60.
  • Show author(s) (2012). The prognostic impact of tumor cell expression of estrogen receptor-alpha, progesterone receptor, and androgen receptor in patients irradiated for nonsmall cell lung cancer. Cancer. 157-163.
  • Show author(s) (2012). Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: The NORDIC-VII Study. Journal of Clinical Oncology. 1755-1762.
  • Show author(s) (2012). Long-term survival data of triple modality treatment of stage IIB-III-IVA cervical cancer with the combination of radiotherapy, chemotherapy and hyperthermia - an update. International Journal of Hyperthermia. 549-553.
  • Show author(s) (2012). High-dose chemotherapy with autologous stem cell support in patients with metastatic non-seminomatous testicular cancer - a report from the Swedish Norwegian Testicular Cancer Group (SWENOTECA). Acta Oncologica. 168-176.
  • Show author(s) (2012). Gene variations in sex hormone pathways and the risk of testicular germ cell tumour: a case-parent triad study in a Norwegian-Swedish population. Human Reproduction. 1525-1535.
  • Show author(s) (2012). Fibroblast growth factor 2—A predictor of outcome for patients irradiated for stage II-III non–small-cell lung cancer. International Journal of Radiation Oncology, Biology, Physics. 442-447.
  • Show author(s) (2012). Expression of cyclin D1a and D1b as predictive factors for treatment response in colorectal cancer. British Journal of Cancer. 1684-1691.
  • Show author(s) (2012). Expression of DSG1 and DSC1 are prognostic markers in anal carcinoma patients. British Journal of Cancer. 756-762.
  • Show author(s) (2012). Chemoradiotherapy of Anal Carcinoma: Survival and Recurrence in an Unselected National Cohort. International Journal of Radiation Oncology, Biology, Physics. E173-E180.
  • Show author(s) (2011). Prognostic impact of erythropoietin expression and erythropoietin receptor expression on locoregional control and survival of patients irradiated for stage II/III non-small-cell lung cancer. International Journal of Radiation Oncology, Biology, Physics. 499-505.
  • Show author(s) (2011). Population-based study of treatment guided by tumor marker decline in patients with metastatic nonseminomatous germ cell tumor: a report from the Swedish-Norwegian testicular cancer group. Journal of Clinical Oncology. 2032-2039.
  • Show author(s) (2011). MicroRNA-15b is induced with E2F-controlled genes in HPV-related cancer. British Journal of Cancer. 1719-1725.
  • Show author(s) (2011). Faglige anbefalinger for behandling ved analcancer. StrålevernRapport. 1-34.
  • Show author(s) (2011). Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study. PLOS ONE. 13 pages.
  • Show author(s) (2010). Prognostic Impact of VEGF and VEGF Receptor 1 (FLT1) Expression in Patients Irradiated for Stage II/III Non-Small Cell Lung Cancer (NSCLC). Strahlentherapie und Onkologie (Print). 307-314.
  • Show author(s) (2010). Paternity and Testicular Function Among Testicular Cancer Survivors Treated With Two to Four Cycles of Cisplatin-Based Chemotherapy. European Urology. 134-140.
  • Show author(s) (2010). Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study. Annals of Oncology. 1858-1863.
  • Show author(s) (2010). Late side effects and quality of life after radiotherapy for rectal cancer. International Journal of Radiation Oncology, Biology, Physics. 1005-1011.
  • Show author(s) (2010). Late side effects and quality of life after radiotherapy for rectal cancer. International Journal of Radiation Oncology, Biology, Physics. 1005-1011.
  • Show author(s) (2010). Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study. Journal of Clinical Oncology. 4649-4657.
  • Show author(s) (2010). Alternative Cyclin D1 Splice Forms Differentially Regulate the DNA Damage Response. Cancer Research. 8802-8811.
  • Show author(s) (2010). A controlled study of risk factors for disease and current problems in long-term testicular cancer survivors. Journal of cancer survivorship. 256-265.
  • Show author(s) (2009). cDNA microarray analysis of serially sampled cervical cancer specimens from patients treated with thermochemoradiotherapy. International Journal of Radiation Oncology, Biology, Physics. 1562-1569.
  • Show author(s) (2009). The personality trait of neuroticism is strongly associated with long-term morbidity in testicular cancer survivors. Acta Oncologica. 842-849.
  • Show author(s) (2009). SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nature Genetics. 1238-1242.
  • Show author(s) (2009). Risk-Adapted Treatment in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: The SWENOTECA Management Program. Journal of Clinical Oncology. 2122-2128.
  • Show author(s) (2009). Pulmonary Function in Long-Term Survivors of Testicular Cancer. Journal of Clinical Oncology. 2779-2786.
  • Show author(s) (2009). Outcome in intermediate or high risk prostate cancer patients receiving radiation dose and hormone therapy. Acta Oncologica. 874-881.
  • Show author(s) (2009). Observational Study of Prevalence of Long-term Raynaud-Like Phenomena and Neurological Side Effects in Testicular Cancer Survivors. Journal of the National Cancer Institute. 1682-1695.
  • Show author(s) (2009). Observational Study of Prevalence of Long-term Raynaud-Like Phenomena and Neurological Side Effects in Testicular Cancer Survivors. Journal of the National Cancer Institute. 1682-1695.
  • Show author(s) (2009). Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicenter randomized trial by The European Society for Hyperthermic Oncology. International Journal of Hyperthermia. 323-334.
  • Show author(s) (2009). Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group. Acta Oncologica. 368-376.
  • Show author(s) (2009). Fear of recurrence in long-term testicular cancer survivors. Psycho-Oncology. 580-588.
  • Show author(s) (2009). Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis. British Journal of Cancer. 1282-1289.
  • Show author(s) (2009). Duration of symptoms, stage at diagnosis and relative survival in colon and rectal cancer. European Journal of Cancer. 2383-2390.
  • Show author(s) (2008). Predicted cardiovascular mortality and reported cardiovascular morbidity in testicular cancer survivors. Journal of cancer survivorship. 128-137.
  • Show author(s) (2008). Predicted cardiovascular mortality and reported cardiovascular morbidity in testicular cancer survivors. Journal of cancer survivorship. 128-137.
  • Show author(s) (2008). Posterior uveal melanoma. Distribution of the sites of origin and patterns of tumour extent in the ocular fundus. British Journal of Ophthalmology. 751-756.
  • Show author(s) (2008). Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation. Eye (London. 1987). 1398-1403.
  • Show author(s) (2008). Palliative surgery for rectal cancer in a national cohort. Colorectal Disease. 336-343.
  • Show author(s) (2008). Incidence of iris melanoma in western Norway. Acta Ophthalmologica. 116-117.
  • Show author(s) (2008). Hyperthermia improves the antitumour effect of metronomic cyclophosphamide in a rat transplantable brain tumour. Radiotherapy and Oncology. 435-442.
  • Show author(s) (2008). Global gene expression analyses reveal changes in biological processes after hyperthermia in a rat glioma model. International Journal of Hyperthermia. 425-441.
  • Show author(s) (2008). Gene expression reveals two distinct groups of anal carcinomas with clinical implications. British Journal of Cancer. 1264-1273.
  • Show author(s) (2008). Fear of recurrence in long-term testicular cancer survivors. Psycho-Oncology.
  • Show author(s) (2008). Dynamic contrast enhanced magnetic resonance imaging of bladder cancer and implications for biological image-adapted radiotherapy. Acta Oncologica. 1257-1264.
  • Show author(s) (2008). Current status of antivascular therapy and targeted treatment in the clinic. International Journal of Hyperthermia. 97-110.
  • Show author(s) (2008). Chronic cancer-related fatigue in long-term survivors of testicular cancer. Journal of Psychosomatic Research. 363-371.
  • Show author(s) (2007). Transient neurological adverse effects following low dose radiation therapy for early stage testicular seminoma. Radiotherapy and Oncology. 137-144.
  • Show author(s) (2007). Time patterns of changes in biomarkers, symptoms and histopathology during pelvic radiotherapy. Acta Oncologica. 639-650.
  • Show author(s) (2007). Strålebehandling av endetarmskreft. Tidsskrift for Den norske legeforening. 3090-3093.
  • Show author(s) (2007). Quantification of S100A12 (EN-RAGE) in blood varies with sampling method, calcium and heparin. Scandinavian Journal of Immunology. 192-201.
  • Show author(s) (2007). Is the sexual function compromised in long-term testicular cancer survivors? European Urology. 1438-1447.
  • Show author(s) (2007). Components of the metabolic syndrome in long-term survivors of testicular cancer. Annals of Oncology. 241-248.
  • Show author(s) (2006). Radiation dose escalation combined with hormone therapy improves outcome in localised prostate cancer. Acta Oncologica. 454-462.
  • Show author(s) (2006). Components of the metabolic syndrome in long-term survivors of testicular cancer. Annals of Oncology.
  • Show author(s) (2006). A concomitant tumour boost in bladder irradiation: Patient suitability and the potential of intensity-modulated radiotherapy. Radiotherapy and Oncology. 98-105.
  • Show author(s) (2005). The assosiation between self-reported physical activity and prevalence of depression and anxiety disorder in long-term survivors of testicular cancer and men i general population sample. Supportive Care in Cancer. 637-646.
  • Show author(s) (2005). The association between self-reported physical activity and prevalence of depression and anxiety disorders in long-term survivors of testicular cancer and men in the general population sample. Supportive Care in Cancer. 637-646.
  • Show author(s) (2005). The association between self-reported physical activity and prevalence of depression and anxiety disorder in long-term survivors of testicular cancer and men in a general population sample. Supportive Care in Cancer. 637-646.
  • Show author(s) (2005). Testing the new ICRU 62 'Planning Organ at Risk Volume' concept for the rectum. Radiotherapy and Oncology. 293-302.
  • Show author(s) (2005). Side effects and cancer-related stress determine quality of life in long-term survivors of testicular cancer. Journal of Clinical Oncology. 3061-3068.
  • Show author(s) (2005). SSucralfate does not ameliorate acute radiation proctitis: Randomised study and meta-analysis. Clinical Oncology. 485-491.
  • Show author(s) (2005). Paternity following treatment for testicular cancer. Journal of the National Cancer Institute. 1580-1588.
  • Show author(s) (2005). Paternity following treatment for testicular cancer. Journal of the National Cancer Institute. 1580-1588.
  • Show author(s) (2005). Paternity Following Treatment for Testicular Cancer. Journal of the National Cancer Institute. 1580-1588.
  • Show author(s) (2005). Adjuvant chemotherapy in colorectal cancer: a joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group. Acta Oncologica. 904-912.
  • Show author(s) (2005). Adjuvant chemotherapy in colorectal cancer: A joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group. Acta Oncologica. 904-912.
  • Show author(s) (2004). Updated European core curriculum for radiotherapists (radiation oncologists). Recommended curriculum for the specialist training of medical practitioners in radiotherapy (radiation oncology) within Europe. Radiotherapy and Oncology. 107-113.
  • Show author(s) (2004). Transient CEA increase at start of oxaliplatin combination therapy for metastatic colorectal cancer. Acta Oncologica. 495-498.
  • Show author(s) (2004). Organ motion, set-up variation and treatment margins in radical radiotherapy of urinary bladder cancer. Radiotherapy and Oncology. 291-304.
  • Show author(s) (2004). On the use of margins for geometrical uncertainties around the rectum in radiotherapy planning. Radiotherapy and Oncology. 11-19.
  • Show author(s) (2004). Multiple sclerosis in Nord-Trondelag County, Norway: a prevalence and incidence study. Acta Neurologica Scandinavica. 378-384.
  • Show author(s) (2004). Multicentre phase II study of Nordic 5-fluorouracil and folinic acid bolus schedule combined with oxaliplatin as first-line treatment of metastatic colorectal cancer. Journal of Clinical Oncology. 31-38.
  • Show author(s) (2004). Karnydanning og tumorkar som mål for kreftterapi. Tidsskrift for Den norske legeforening. 1919-1922.
  • Show author(s) (2004). Faecal calprotectin and lactoferrin as markers of acute radiation proctitis: A pilot study of eight stool markers. Scandinavian Journal of Gastroenterology. 1113-1118.
  • Show author(s) (2004). Evaluation of a new method for calculation of cumulative doses in the rectum wall using repeat CT scans. Acta Oncologica. 388-395.
  • Show author(s) (2004). Blood pressure and body mass index (BMI) in testicular cancer survivors. Annals of Oncology. 112-112.
  • Show author(s) (2004). Acute morbidity related to treatment volume during 3D-conformal radiation therapy for prostate cancer. Radiotherapy and Oncology. 43-53.
  • Show author(s) (2004). A Monte Carlo study of the impact of the choice of rectum volume definition on estimates of equivalent uniform doses and the volume parameter. Physics in Medicine and Biology. 3341-3352.
  • Show author(s) (2003). The level of physical activity in long-term surdivors of testicular cancer. European Journal of Cancer. 6 pages.
  • Show author(s) (2003). Sustained Prothrombotic profile after Hip Replacement Surgery. The Influence of Prolonged Prophylaxis with Dalteparin. Thrombosis and Haemostasis. 971-975.
  • Show author(s) (2003). Profiles and time course of acute radiation toxicity symptoms during conformal radiotherapy for cancer of the prostate. Acta Oncologica. 741-748.
  • Show author(s) (2003). Gonadal hormones in longterm survivors 10 years after treatment for unilateral testicular cancer. European Urology. 322-328.
  • Show author(s) (2003). Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer. European Urology. 7 pages.
  • Show author(s) (2003). Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer. European Urology. 322-328.
  • Show author(s) (2003). Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer. European Urology. 322-328.
  • Show author(s) (2003). Carcinoembryonic antigen surge in metastatic colorectal cancer patients responding to Oxaliplatin combination chemotherapy: Implications for tumor marker monitoring and guidelines. Journal of Clinical Oncology. 4466-4467.
  • Show author(s) (2003). Brachytherapy for prostatic cancer: a systematic review of clinical and cost effectiveness. European Urology. 40-46.
  • Show author(s) (2003). Brachytherapy for prostate cancer: A systematic review of clinical and cost effectiveness. European Urology. 40-46.
  • Show author(s) (2002). The influence of combretastatin A-4 and vinblastine on interstitial fluid pressure in BT4An rat gliomas. Cancer Letters. 209-217.
  • Show author(s) (2002). Norwegian Oncologists' Expectations of Intensity-modulated Radiotherapy. Acta Oncologica. 562-565.
  • Show author(s) (2002). Hyperthermia exhibits anti-vascular activity in the s.c. BT4An rat glioma: lack of interaction with the angiogenesis inhibitor batimastat. International Journal of Hyperthermia. 141-152.
  • Show author(s) (2002). Cardiac and pulmonary doses and complication probabilities in standard and conformal tangential irradiation in conservative management of breast cancer. Radiotherapy and Oncology. 173-183.
  • Show author(s) (2002). Brakyterapi ved prostatakreft. Tidsskrift for Den norske legeforening. 2795-2798.
  • Show author(s) (2001). Partially wedged beams improve radiotherapy treatment of urinary bladder cancer. Radiotherapy and Oncology. 21-30.
  • Show author(s) (2001). Oxaliplatin-induced haematological emergency with an immediate severe thrombocytopenia and hemolysis. Case report. Acta Oncologica. 882-883.
  • Show author(s) (2001). Dosimetric verification of a dedicated 3D treatment planning system for episcleral plaque therapy. International Journal of Radiation Oncology, Biology, Physics. 1159-1166.
  • Show author(s) (2000). The new tubulin-inhibitor combretastatin A-4 enhances thermal damage in the BT4An rat glioma. International Journal of Radiation Oncology, Biology, Physics. 645-652.
  • Show author(s) (2000). The new tubulin-inhibitor combretastatin A-4 enhances thermal damage in the BT4An rat glioma. International Journal of Radiation Oncology, Biology, Physics. 645-652.
  • Show author(s) (2000). Partially wedged fields formed by dynamic collimation. Medical Physics (Lancaster). 527-534.
  • Show author(s) (2000). Partially wedged fields formed by dynamic collimation. Medical Physics (Lancaster). 527-534.
  • Show author(s) (2000). Dose-volume analysis of different stereotactic radiotherapy mono-isosentric techniques. Acta Oncologica. 157-163.
  • Show author(s) (2000). Dose-volume analysis of different stereotactic radiotherapy mono-isocentric techniques. Acta Oncologica. 157-163.
  • Show author(s) (2000). Behandling av nyrekreft med fjernmetastaser. Tidsskrift for Den norske legeforening. 2274-2278.
  • Show author(s) (2000). Behandling av nyrekreft med fjernmetastaser. Tidsskrift for Den norske legeforening. 2274-2278.
  • Show author(s) (2000). Behandling av nyrekreft med fjernmetastaser. Tidsskrift for Den norske legeforening. 2274-2278.
  • Show author(s) (2000). Adapting the waterproof BMS-96 diode array for isodose measurements of intensity modulated beams. Medical Dosimetry. 93-97.
  • Show author(s) (2000). Adapting the waterproof BMS-96 diode array for isodose measurements of intensity modulated beams. Medical Dosimetry. 93-97.
  • Show author(s) (2000). ARCON: accelerated radiotherapy with carbogen and nicotinamide in head and neck squamous cell carcinomas. The experience of the Co-operative Group of Radiotherapy of the European Organization for Research and Treatment of Cancer (EORTC). Radiotherapy and Oncology. 111-119.
  • Show author(s) (2000). ARCON: accelerated radiotherapy with carbogen and nicotinamide in head and neck squamous cell carcinomas. The experience of the Co-operative Group of Radiotherapy of the European Organization for Research and Treatment of Cancer (EORTC). Radiotherapy and Oncology. 111-119.
  • Show author(s) (1999). Tissue prostate-specific antigen and androgen receptor immunoreactivity in prostate cancer biopsies before, during and after neo-adjuvant androgen deprivation followed by radiotherapy. European Urology. 116-122.
  • Show author(s) (1999). Tissue PSA and androgen receptor immunoreactivity in prostate cancer biopsies before, during and after neo-adjuvant androgen deprivation followed by radiotherapy. European Urology. 116-122.
  • Show author(s) (1999). Status of clinical hyperthermia. Acta Oncologica. 863-873.
  • Show author(s) (1999). ARCON: accelerated radiotherapy with carbogen and nicotinamide in non small cell lung cancer: a phase I/II study by EORTC. Radiotherapy and Oncology. 149-156.
  • Show author(s) (1998). Lymphocele after retroperitoneal surgery for testicular or extragonadal germ cell tumors may mimic recurrence. Urology. 833-834.
  • Show author(s) (1998). Lymphocele after retroperitoneal surgery for testicular or extragonadal germ cell tumors may mimic recurrence. Urology. 833-834.
  • Show author(s) (1997). for the Swedish-Norwegian Testis Cancer Group (SWENOTECA). European Journal of Cancer. 1038-1044.
  • Show author(s) (1997). Risk-adapted treatment of clinical stage I nonseminoma testis cancer. European Journal of Cancer. 1038-1044.
  • Show author(s) (1997). Risk-adapted treatment of clinical stage I non-seminaoma testis cancer. European Journal of Cancer. 1038-1044.
  • Show author(s) (1997). Quality assurance in conformal radiotherapy. DYNARAD consensus report on pratice guidelines. Radiotherapy and Oncology. 217-223.
  • Show author(s) (1997). Proliferation, migration and invasion of human glioma cells exposed to paclitaxel (Taxol) in vitro. British Journal of Cancer. 1744-1762.
  • Show author(s) (1997). Fibrosarcoma in children. A rare tumour with long-term survival even with advanced disease. A report of 3 cases. Acta Oncologica. 438-440.
  • Show author(s) (1997). Fibrosarcoma in children. Acta Oncologica. 438-440.
  • Show author(s) (1996). Use of the vasodilator sodium nitroprusside during local hyperthermia: Effects on tumor temperature and tumor response in a rat tumor model. International Journal of Radiation Oncology, Biology, Physics. 403-415.
  • Show author(s) (1996). Clinical assessment of conformal radiotherapy results. Acta Oncologica. 41-57.
  • Show author(s) (1996). Cisplatin-based chemotherapy in a renal transplant recipient with metastatic germ cell testicular cancer. Acta Oncologica. 759-761.
  • Show author(s) (1995). The use of non-proven therapy among patients treated in Norwegian oncological departments. A cross-sectional national multicentre study. European Journal of Cancer. 1785-1789.
  • Show author(s) (1995). Randomized trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. The Lancet. 540-543.
  • Show author(s) (1993). Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of vater - Results of a controlled, prospective, randomised multicentre study. European Journal of Cancer. 698-703.
  • Show author(s) (1978). A syndrome of factor VVI deficiency and abnormal platelet release reaction. Scandinavian Journal of Haematology. 206-214.
Academic lecture
  • Show author(s) (2014). Management of clinical stage I seminomatous testicular cancer: A report from SWENOTECA.
  • Show author(s) (2006). The present conditions and the future prospects of clinical test of hyperthermia in Europe.
  • Show author(s) (2006). Posterior uveal melanoma. Distribution of initiation sites and patterns of tumour extent in the ocular fundus.
  • Show author(s) (2005). Gonadal hormones, sperm counts and post-treatment paternity in long-term survivors of unilateral testicular cancer.
  • Show author(s) (2005). Får pasienter med lokalisert prostatakreft adekvat tilbud om radikal strålebehandling?
  • Show author(s) (2005). A randomised phase III multicenter trial comparing irinotecan in combination with 5FU and folinic acid (FU/FA) given according to the Nordic bolus schedule to irinotecan in combination with 5FU/FA given according to the bolus/infused de Gramont schedule, in patients with metastatic colorectal cancer.
  • Show author(s) (2005). A concomitant tumour boost in bladder irradiation: Patient suitability and the potensial of intensity-modulated radiotherapy.
  • Show author(s) (2004). Post-treatment paternity in testicular cancer survivors.
  • Show author(s) (2004). Post-treatment paternity in testicular cancer survivors.
  • Show author(s) (2004). Dose response in a series of 495 patients with early prostate cancer.
  • Show author(s) (2004). Blood pressure and body mass index (BMI) in testicular cancer survivors.
  • Show author(s) (2004). Blood pressure and Body mass index in testicular cancer survivors.
  • Show author(s) (2004). A test of the ICRU 62 "Planning organ at Risk Volume" concept for the rectum.
  • Show author(s) (2004). A Monte Carlo study of the impact of the choice of rectum volume definition on estimates of the equivalent uniform doses and the volume parameter.
  • Show author(s) (2003). Regional hyperthermia added to chemoradiotherapy in advanced cervical cancer: Multicenter international feasibility.
  • Show author(s) (2003). Only colon cancer patients with Dukes stage C benefit from adjuvant chemotherapy with 5-fluorouracil and levamisole among 425 patients with operable colorectal cancer in a Norwegian randomised study.
  • Show author(s) (2003). Adjuvant chemotherapy in colorectal cancer: Joint analyses of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group.
  • Show author(s) (2001). Verification of a 3-D treatment planning system for episcleral brachytherapy.
  • Show author(s) (2001). Cardiac and pulmonary doses and complication probabilities in standard and conformal tangential irradiation in conservative management of breast cancer.
Abstract
  • Show author(s) (2014). Scandinavian studies of gene variants and risk of testicular germ cell tumor. 8th CIS Abstract book.
  • Show author(s) (2014). Particle therapy in Norway - report from the national project group. Radiotherapy and Oncology. 314-314.
  • Show author(s) (2013). Investigation of six testicular germ cell tumor susceptibility genes suggests a parent-of-origin effect in the tumor suppressor gene SPRY4. Norsk Epidemiologi, Supplement. 44-44.
  • Show author(s) (2012). Bilateral testicular cancer within two prospective, population-based SWENOTECA protocols in clinical stage I nonseminoma. Journal of Clinical Oncology. 1 pages.
  • Show author(s) (2009). Individualized intensification of treatment based on tumor marker decline in metastatic nonseminomatous germ cell testicular cancer (NSGCT): A report from the Swedish Norwegian Testicular Cancer Group, SWENOTECA. Journal of Clinical Oncology. 2 pages.
  • Show author(s) (2008). Topographical distribution of posterior uveal melanoma, choroidal nevi, and congenital hypertrophy of the retinal pigment epithelium. Acta Ophthalmologica. 8-8.
  • Show author(s) (2008). Rectal cancer with macroscopic peritoneal involvement - clinical challenges and consequences. Colorectal Disease. 23 pages.
  • Show author(s) (2008). Pulmonary function in long-term testicular cancer survivors. Annals of Oncology. viii205.
  • Show author(s) (2007). Is neuroticism associated with long-term morbidity in testicular cancer survivors? Psycho-Oncology.
  • Show author(s) (2007). Fear of recurrence in long-term testicular cancer survivors. Psycho-Oncology.
  • Show author(s) (2006). Self-reported paresthesias, Raynaud's phenomena, tinnitus, and hearing impairment in a large cohort of long-term testicular cancer (TG) survivors. Journal of Clinical Oncology. 228S-228S.
  • Show author(s) (2006). Self-reported paresthesia, Raynaud,s phenomena, tinnitus, and hearing impairment in long-term testicular cancer (TC) survivors. Journal of Clinical Oncology. 228s.
  • Show author(s) (2006). Cardiovascular (CV)morbidity and predicted mortality in long-term testicular cancer (TC) survivors. Annals of Oncology. 443PD.
  • Show author(s) (2005). Self-reported paresthesia, Raynaud’s phenomena, tinnitus, and hearing impairment in long-term testicular cancer (TC) survivors. European Journal of Cancer.
  • Show author(s) (2005). Metabolic syndrome in long-term testicular cancer survivors. Proceedings of the Annual Meeting of the American Society for Clinical Oncology.
  • Show author(s) (2005). Metabolic syndrome in long-term testicular cancer survivors. Journal of Clinical Oncology.
  • Show author(s) (2005). Gonadal hormones, sperm counts and post-treatment paternity in long-term survivors of unilateral testicular cancer. European Journal of Cancer. 228s.
  • Show author(s) (2004). Working ability and educational level among long-term survivors of teasticular cancer (TCSS) compared to a general population (GenPop). Proceedings of the Annual Meeting of the American Society for Clinical Oncology. 1 pages.
  • Show author(s) (2004). Testing the new ICRU 62 'planning organ at risk volume' concept for the rectum. Radiotherapy and Oncology.
  • Show author(s) (2004). Post-treatment paternity in testicular cancer survivors. Journal of Clinical Oncology. 388S-388S.
  • Show author(s) (2004). Post-treatment paternity in testicular cancer survivors. Proceedings of the Annual Meeting of the American Society for Clinical Oncology. 1 pages.
  • Show author(s) (2004). Blood pressure and body mass index (BMI) in testicular cancer survivors. Annals of Oncology. 112-112.
  • Show author(s) (2003). Treatment precision and treatment effect in conformal radiotherapy of urinary bladder cancer - preliminary results. Radiotherapy and Oncology. S94-S94.
  • Show author(s) (2003). Risk-adapted brief adjuvant chemotherapy in clinical stage I (CSI) nonseminomatous germ cell testicular cancer (NSGCT). Proceedings of the Annual Meeting of the American Society for Clinical Oncology. 1 pages.
Academic literature review
  • Show author(s) (2009). Cancer therapy targeted at cellular signal transduction mechanisms: strategies, clinical results, and unresolved issues. European Journal of Pharmacology. 6-22.
  • Show author(s) (2008). Analkreft. Tidsskrift for Den norske legeforening. 198-200.
  • Show author(s) (2004). Conformal radiotherapy of urinary bladder cancer. Radiotherapy and Oncology. 387-398.

More information in national current research information system (CRIStin)